Consistent benefits seen for White and Asian populations and consistent lack of benefits seen in Black populations.
Your search for evid returned 477 results
NurOwn consists of autologous mesenchymal stem cells that have been induced to secrete neurotrophic factors.
Higher major pathological response seen for patients with resectable NSCLC treated with combo versus durvalumab alone.
High treatment success rate observed for vaginal and cesarean births across all bleeding causes.
No significant reduction seen in percent of patients with urgent care or emergency department visits or hospitalization.
Molnupiravir and nirmatrelvir-ritonavir combination therapy should be considered for patients within 5 days of symptom onset.
Review and meta-analysis show improvements in functional exercise capacity vs standard of care.
Screening with blood pressure measurements has substantial net benefits and is recommended throughout pregnancy.
Combination of a patch and fast-acting nicotine replacement therapy also effective.
Safety concerns to consider for youth with diabetes who are restricting carbohydrates include growth deceleration, poor bone health.